These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26863791)

  • 1. [Pelvic exenteration--our experience].
    Nedialkov K; Magunska N; Bechev B
    Akush Ginekol (Sofiia); 2015; 54(9):19-23. PubMed ID: 26863791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?
    Martínez A; Filleron T; Vitse L; Querleu D; Mery E; Balague G; Delannes M; Soulie M; Pomel C; Ferron G
    Gynecol Oncol; 2011 Mar; 120(3):374-9. PubMed ID: 21215437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
    Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
    J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
    Teixeira SC; Ferenschild FT; Solomon MJ; Rodwell L; Harrison JD; Young JM; Vasilaras A; Eisinger D; Lee P; Byrne C
    Eur J Surg Oncol; 2012 Apr; 38(4):361-6. PubMed ID: 22265840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
    Zhang Z; Zang R; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tumor size on outcomes following pelvic exenteration.
    Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
    Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
    Silver DF; Ashwell TR
    Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
    Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
    Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration: surgical aspects and analysis of early and late morbidity in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):273-81. PubMed ID: 22191127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series.
    Moutardier V; Houvenaeghel G; Lelong B; Mokart D; Delpero JR
    Gynecol Oncol; 2003 Apr; 89(1):155-9. PubMed ID: 12694670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration--reconsidering the procedure.
    Bacalbasa N; Balescu I
    J Med Life; 2015; 8(2):146-9. PubMed ID: 25866569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
    Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
    World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial experience in exenteration interventions in the pelvis].
    Cibula D; Svárovský J; Ungár L; Babjuk M; Pesková M; Gürlich R; Zivný J; Freitag P; Dundr P; Mares P
    Ceska Gynekol; 2004 Nov; 69(6):483-8. PubMed ID: 15633419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary pelvic exenteration in cervical cancer patients.
    Ungar L; Palfalvi L; Novak Z
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.
    Roos EJ; Van Eijkeren MA; Boon TA; Heintz AP
    Int J Gynecol Cancer; 2005; 15(4):624-9. PubMed ID: 16014116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration--our initial experience in 15 cases.
    Căpîlna ME; Moldovan B; Szabo B
    Eur J Gynaecol Oncol; 2015; 36(2):142-5. PubMed ID: 26050350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.